Patents Assigned to Daxor Corporation
  • Patent number: 9002656
    Abstract: A computer-based method for automatically determining total body albumin of a living being based on the calculated intravascular albumin, the calculated observed ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time, and the baseline of expected ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time.
    Type: Grant
    Filed: October 17, 2011
    Date of Patent: April 7, 2015
    Assignee: Daxor Corporation
    Inventors: Joseph Feldschuh, Jonathan Feldschuh
  • Patent number: 9002657
    Abstract: A computer-based method for automatically determining total body albumin of a living being based on the calculated intravascular albumin, the calculated observed ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time, and the baseline of expected ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: April 7, 2015
    Assignee: Daxor Corporation
    Inventors: Joseph Feldschuh, Jonathan Feldschuh
  • Publication number: 20130096837
    Abstract: An automated blood analyzer that analyzes blood of a living being including one or more sample carriers that hold samples of blood of a living being, each sample having been withdrawn from the living being at a different point in time after the living being was injected with radio-labeled albumin, means for calculating a set of data points representing blood volume of the living being at the one or more points in time after the living being was injected with the radio-labeled albumin based on detected counts of the radio-labeled albumin in the samples of blood, wherein the automated blood analyzer uses the set of data points for further analysis of the blood of the living being, and a quality control module that at least one of calibrates the means for calculating or verifies that the means for calculating operates within predetermined parameters.
    Type: Application
    Filed: March 9, 2012
    Publication date: April 18, 2013
    Applicant: DAXOR CORPORATION
    Inventors: Joseph FELDSCHUH, Jonathan FELDSCHUH
  • Publication number: 20130096836
    Abstract: A computer-based method for automatically determining total body albumin of a living being based on the calculated intravascular albumin, the calculated observed ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time, and the baseline of expected ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time.
    Type: Application
    Filed: October 17, 2011
    Publication date: April 18, 2013
    Applicant: DAXOR CORPORATION
    Inventors: Joseph FELDSCHUH, Jonathan FELDSCHUH
  • Publication number: 20130096846
    Abstract: A computer-based method for automatically determining total body albumin of a living being based on the calculated intravascular albumin, the calculated observed ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time, and the baseline of expected ratio of amount of albumin in the intravascular system to amount of albumin in the extravascular system at the first time.
    Type: Application
    Filed: March 9, 2012
    Publication date: April 18, 2013
    Applicant: DAXOR CORPORATION
    Inventors: Joseph FELDSCHUH, Jonathan FELDSCHUH
  • Publication number: 20080195023
    Abstract: Method of optimization of blood and system for customizing blood for future use of an individual which includes: obtaining a unique blood volume measurement from the individual or a potential blood donor; administering an epoetin alfa medication to the individual or potential blood donor for stimulating bone marrow to increase production of red blood cells in accordance with information obtained from the measurement of the blood volume of the individual or the potential blood donor; and storage of blood obtained from the individual or potential blood donor if the blood donor is qualified in accordance with acceptable medical procedures to donate blood.
    Type: Application
    Filed: February 9, 2007
    Publication date: August 14, 2008
    Applicant: Daxor Corporation
    Inventor: Joseph Feldschuh
  • Patent number: 5529189
    Abstract: A disposable single-use kit for administering a precise dose of radioactive tracer to a subject with an accuracy of at least 99.9% by weight. The kit comprises a syringe, pre-filled with a known quantity of a radioactive tracer as injectate. The back of a small-bore needle is affixed to the syringe front. The front of a removable plastic needle cover incorporates airtight means for creating and maintaining an airlock in the needle front, thereby to prevent any contact between the tracer and the cover and so preclude any loss of tracer upon removal of the cover from the needle. A valve normally seals the syringe back, the valve including actuatable means for enabling a fluid flow into the syringe back, both for pre-filling of the syringe with injectate and for flushing of the injectate from the syringe into the subject.
    Type: Grant
    Filed: August 2, 1995
    Date of Patent: June 25, 1996
    Assignee: Daxor Corporation
    Inventor: Joseph Feldschuh
  • Patent number: 5024231
    Abstract: A multi-point method of determining a time-zero blood volume by the tracer dilution technique. A tracer is injected into the blood stream of a living being, and a plurality of mixed samples of blood and tracer are removed from the blood stream at a corresponding plurality of measured time intervals subsequent to the injecting step. A blood portion volume corresponding to each time interval is automatically determined from the tracer level in the mixed samples, and a time-zero blood portion volume is automatically calculated from the determined blood portion volumes and time intervals.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: June 18, 1991
    Assignee: Daxor Corporation
    Inventors: Joseph Feldschuh, Jonathan A. Feldschuh